Interferon-β–Induced Pulmonary Arterial Hypertension: Approach to Diagnosis and Clinical Monitoring

A 48-year-old woman who had been receiving long-term interferon-β for 8 years for multiple sclerosis developed drug-induced World Health Organization group I pulmonary arterial hypertension. Triple therapy for pulmonary arterial hypertension and suspension of interferon-β led to improvement from a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Farhan, Kozitza, Callyn, Chybowski, Amy, Goss, Kara N., Berei, Theodore, Runo, James, Eldridge, Marlowe, Chesler, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311374/
https://www.ncbi.nlm.nih.gov/pubmed/34317680
http://dx.doi.org/10.1016/j.jaccas.2021.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311374/
https://www.ncbi.nlm.nih.gov/pubmed/34317680
http://dx.doi.org/10.1016/j.jaccas.2021.02.005

Ejemplares similares